Liang W, Lv H, Chen C, Sun Y, Hui DS, Mok CKP. Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong. Int J Infect Dis. 2023 Jul 20:S1201-9712(23)00659-
Background: Seasonal influenza infection cases decline significantly in Hong Kong since the COVID-19 pandemic has begun in 2020. This also reduced the opportunities of reinducing influenza-specific antibodies in the community. The levels of antibodies in protecting against recently circulating influenza A viruses in post COVID-19 era are unclear.
Methods: Paired plasma samples which were collected in 2021 and 2022 from 479 healthy adults in Hong Kong were tested. The neutralizing titer in plasma against the influenza A (H1N1) and (H3N2) viruses circulating before or after the COVID-19 outbreak were determined using microneutralization assay.
Results: The H1N1 and H3N2 vaccine strains which have been selected for the 2022/23 season are phylogenetically closed to the recently circulating viruses. In samples collected in 2022, only 14.61% and 0.42% showed neutralization titer MN50 ≥1:20 to the H1N1 A/Wisconsin/588/2019 (H1/Wis19) and H3N2 A/Darwin/6/2021 (H3/Dar21), respectively. Participants who reported receiving flu vaccination annually had higher seropositive rate to H1/Wis19 than those who had never received flu vaccine (28.06% vs 5.30%). SS: Our results indicate adults in Hong Kong are generally lack of neutralizing antibodies against the circulating influenza A viruses especially the H3N2, highlighting the importance of promoting flu vaccination in the post-COVID-19 era.
Methods: Paired plasma samples which were collected in 2021 and 2022 from 479 healthy adults in Hong Kong were tested. The neutralizing titer in plasma against the influenza A (H1N1) and (H3N2) viruses circulating before or after the COVID-19 outbreak were determined using microneutralization assay.
Results: The H1N1 and H3N2 vaccine strains which have been selected for the 2022/23 season are phylogenetically closed to the recently circulating viruses. In samples collected in 2022, only 14.61% and 0.42% showed neutralization titer MN50 ≥1:20 to the H1N1 A/Wisconsin/588/2019 (H1/Wis19) and H3N2 A/Darwin/6/2021 (H3/Dar21), respectively. Participants who reported receiving flu vaccination annually had higher seropositive rate to H1/Wis19 than those who had never received flu vaccine (28.06% vs 5.30%). SS: Our results indicate adults in Hong Kong are generally lack of neutralizing antibodies against the circulating influenza A viruses especially the H3N2, highlighting the importance of promoting flu vaccination in the post-COVID-19 era.
See Also:
Latest articles in those days:
- The evolution and transmission dynamics of H3N2 influenza virus identified in a respiratory disease outbreak in companion dogs in Alabama, USA 9 hours ago
- Structural and functional characterization of hemagglutinin E190D and Q226H minor variants in human H5N1 A/British Columbia/PHL-2032/2024 9 hours ago
- Spatial risk factors associated with outbreaks of highly pathogenic avian influenza in Pennsylvania’s commercial poultry farms 9 hours ago
- [preprint]H9N2 avian influenza virus in Bangladesh: three genetically distinct co-circulating subgroups retain a largely conserved antigenic phenotype 9 hours ago
- [preprint]Endogenous serine proteases in MDCK sublines support trypsin-independent influenza A virus replication 9 hours ago
[Go Top] [Close Window]


